The cost‐effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model
- 19 August 2013
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 30 (10) , 1236-1244
Abstract
Aims: To estimate the cost‐effectiveness of training in flexible intensive insulin therapy [as provided in the Dose Adjustment for Normal Eating (DAFNE) structured education programme] compared with no training for adults with Type 1 diabetes mellitus in theUKusing the Sheffield Type 1 Diabetes Policy Model.Methods: The Sheffield Type 1 Diabetes Policy Model was used to simulate the development of long‐term microvascular and macrovascular diabetes‐related complications and the occurrence of diabetes‐related adverse events in 5000 adults with Type 1 diabetes. Total costs and quality‐adjusted life years were estimated from a National Health Service perspective over a lifetime horizon, discounted at a rate of 3.5%. The treatment effectiveness ofDAFNEwas modelled as a reduction in HbA1cthat affected the risk of developing long‐term diabetes‐related complications. Probabilistic and structural sensitivity analyses were conducted.Results: DAFNEresulted in greater life expectancy and reduced incidence of some diabetes‐related complications compared with noDAFNE.DAFNEwas found to generate an average of 0.0294 additional quality‐adjusted life years for an additional cost of £426 per patient, leading to an incremental cost‐effectiveness ratio of £14 400 compared with noDAFNE. There was a 54% probability thatDAFNEwould be cost‐effective at a willingness‐to‐pay threshold of £20 000 per quality‐adjusted life year.Conclusions: The results of this study suggest thatDAFNEis a cost‐effective structured education programme for people with Type 1 diabetes and support its provision by the National Health Service in theUK.Keywords
This publication has 20 references indexed in Scilit:
- A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR)Diabetic Medicine, 2011
- Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetesDiabetes Research and Clinical Practice, 2010
- The 25-Year Incidence of Visual Impairment in Type 1 Diabetes MellitusOphthalmology, 2010
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 DiabetesOphthalmology, 2009
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIIOphthalmology, 2008
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Cost‐effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UKDiabetic Medicine, 2004
- Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trialBMJ, 2002
- Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications TrialKidney International, 1995
- Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 monthsDiabetologia, 1983